Focusing on the World Health Organization Priority Pathogen list, one sees Gram-Negative organisms and carbapenem resistance as critical. There are multiple factors in the growing prevalence of emerging antibiotic resistance. Carbapenemase producers are spreading now also in the community. In the era of globalization, does resistance to not-yet-approved antibiotics mean that antibiotic resistance will be the next pandemic?

Presenter: Professor. Patrice Nordmann

Professor. Patrice Nordmann is chair of the Medical and Molecular Microbiology Dept, Section of Medicine, and founder and director of the National Reference Center for Emerging Antibiotic Resistance (Switzerland) at the University of Fribourg, and head of the Emerging Antibiotic Resistance foreign laboratory of the INSERM located also at the University of Fribourg. He has been the Chief of the Dept of Medical Microbiology at Hospital Bicêtre, Paris and Professor of Medical Microbiology at the South-Paris University from 1994 to 2013 His research focuses on the emerging antibiotic resistance in Gram negative bacteria from fundamental genetics to biochemistry, and clinical applications such as development of rapid diagnostic tests for identification of multidrug resistance.